Gene · 1903
Papers1,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety evaluation of etrasimod for ulcerative colitis based on the FAERS database. | Sci Rep | 2025 | 41120400 | PubTator, text mining | PubMed |
| Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications. | J Pers Med | 2025 | 41003134 | PubTator, text mining | PubMed |
| Discovery and SAR study of highly selective and potent 1,2,4-oxadiazole-based S1PR1 agonists. | Eur J Med Chem | 2025 | 40911968 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| Effects of sphingolipid metabolism related genes-SPTLC1, ORMDL3, SPHK1 and S1PR3 polymorphisms on susceptibility to hashimoto's thyroiditis. | J Endocrinol Invest | 2025 | 40782218 | PubTator, text mining | PubMed |
| Regulator of G protein signaling 2 as a suppressor of sphingosine-1-phosphate 2- and 3-mediated signaling in colon cancer cells. | J Biol Chem | 2025 | 40754247 | PubTator, text mining | PubMed |
| DNA repair and inflammatory response genes play a central role in protecting patients with long-standing type 1 diabetes from vascular complications. | J Diabetes Complications | 2025 | 40570537 | PubTator, text mining | PubMed |
| Apolipoprotein M attenuates age-related macular degeneration phenotypes via sphingosine-1-phosphate signaling and lysosomal lipid catabolism. | Nat Commun | 2025 | 40555726 | PubTator, text mining | PubMed |
| Etrasimod: Modulating Sphingosine-1-Phosphate Receptors to Treat Ulcerative Colitis. | J Clin Med | 2025 | 40507651 | PubTator, text mining | PubMed |
| Integrated systems biology approach reveals the potential mechanism of Guanxinning in treating coronary heart disease complicated with major depressive disorder through S1PR3 regulation. | Comput Biol Med | 2025 | 40472508 | PubTator, text mining | PubMed |
| Sphingosine-1-phosphate signalling activates E-Syt1 to facilitate HDL-derived cholesterol transport. | Nat Cell Biol | 2025 | 40437229 | PubTator, text mining | PubMed |
| S1PR3 inhibition impairs cell cycle checkpoint via the AKT/WEE1 pathway in oral squamous cell carcinoma. | J Transl Med | 2025 | 40410851 | PubTator, text mining | PubMed |
| Characterization of functionally relevant G protein-coupled receptors in endometriotic epithelial cells. | Cell Signal | 2025 | 40381972 | PubTator, text mining | PubMed |
| Integrating single-cell sequencing and transcriptome analysis to unravel the mechanistic role of sialylation-related genes in sepsis-induced acute respiratory distress syndrome. | Front Immunol | 2025 | 40375981 | PubTator, text mining | PubMed |
| Identification of tRF-29-79MP9P9NH525 as a biomarker and tumor suppressor of gastric cancer via regulating KIF14/AKT pathway. | Cell Death Discov | 2025 | 40374610 | PubTator, text mining | PubMed |
| Sphingolipids as key mediators in folliculogenesis and female fertility. | Life Sci | 2025 | 40348177 | PubTator, text mining | PubMed |
| Antagonizing the S1P-S1P3 Axis as a Promising Anti-Angiogenic Strategy. | Metabolites | 2025 | 40137142 | PubTator, text mining | PubMed |
| Inhibition of sphingosine 1-phosphate receptor 3 ameliorates bleomycin-induced pulmonary fibrosis by suppressing macrophage M2 polarization. | Genes Dis | 2025 | 40092491 | PubTator, text mining | PubMed |
| Dual action of sphingosine 1-phosphate pathway in in vitro models of global cerebral ischemia. | Neurobiol Dis | 2025 | 40068722 | PubTator, text mining | PubMed |
| Transplantation of engineered endothelial progenitor cells with H19 overexpression promotes arterial reendothelialization and inhibits neointimal hyperplasia. | J Tissue Eng | 2025 | 39974657 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1903/papers?page=3